Cecco, Sara http://orcid.org/0000-0002-0656-7521
Puligheddu, Stefano
Fusaroli, Michele
Gerratana, Lorenzo
Yan, Miao
Zamagni, Claudio
De Ponti, Fabrizio
Raschi, Emanuel
Article History
Accepted: 24 March 2024
First Online: 2 May 2024
Declarations
:
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
: C.Z. has received grants from Novartis, Roche, Eisai, AstraZeneca, Pfizer, PharmaMar, Tesaro, Pierre Fabre, Ist. Gentili, Teva, Seagen, Eli Lilly, Celgene, MSD, GSK, Amgen, and Daiichi; has received support for attending meetings and/or travel from Novartis, Roche, Pfizer, PharmaMar, Tesaro, Pierre Fabre, Ist. Gentili, and Celgene; and has participated in data safety monitoring or advisory boards for Novartis, Roche, Eisai, AstraZeneca, Pfizer, PharmaMar, Amgen, Tesaro, Quintiles IMS, Eli Lilly, Celgene, MSD, GSK, and Daiichi. L.G. reports serving as a consultant/advisor for Lilly, Novartis, AstraZeneca, GlaxoSmithKline, and Incyte. S.C., S.P., M.F., M.Y., F.D.P., and E.R. have no conflicts of interest that are directly relevant to the content of this article.
: The datasets analyzed during the current study are available in the public domain: .
: Codes are available upon reasonable request to the authors.
: S.C. conceived the study. E.R., M.F., S.P., and S.C. contributed to study design. S.P. and M.F. contributed to the acquisition and analysis of data. S.C. drafted the manuscript. All authors contributed to the interpretation of data, critically revised the manuscript, and provided final approval.
: This article does not contain any studies with human participants performed by any of the authors. This study is based on anonymous data that can be downloaded from a publicly available source. Therefore, no ethical approval is required.
: Not applicable.
: Not applicable.